Literature DB >> 31806523

Duration of the psychosis prodrome.

Albert R Powers1, Jean Addington2, Diana O Perkins3, Carrie E Bearden4, Kristin S Cadenhead5, Tyrone D Cannon6, Barbara A Cornblatt7, Daniel H Mathalon8, Larry J Seidman9, Ming T Tsuang5, Elaine F Walker10, Thomas H McGlashan11, Scott W Woods11.   

Abstract

The recognition of a prodromal period preceding the onset of frank psychosis dates back to its first descriptions. Despite insights gained from a prospective approach to the study of the Clinical High Risk syndrome for psychosis (CHR-P), a prospectively-based understanding of the duration of the psychosis prodrome and the factors that may influence is not well-established. Here we analyze data from the second North American Prodrome Longitudinal Study (NAPLS-2) to characterize prodrome duration in those who converted to psychosis. Of the 764 participants identified as being at CHR-P, 94 converted to psychosis and 92 of these had recorded estimates of prodrome onset. Estimates of prodrome duration were derived from CHR-P syndrome onset and conversion dates from the Structured Interview for Psychosis-risk Syndromes. Results identified a mean prodrome duration of 21.6 months. Neither CHR-P sub-syndrome nor medication exposure was found to significantly influence prodrome duration in this sample. These results provide the most precise estimate of prodrome duration to date, although results are limited to prodromes identified by ascertainment as being at CHR-P. Our findings also suggest a rule of thirds with regard to prodrome duration in those followed for two years: one third of CHR-P patients who convert will do so by 1 year after CHR-P syndrome onset, another third 1-2 years after onset, and the final third more than 2 years after onset.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Clinical high risk; Duration; Prodrome; Psychosis

Mesh:

Year:  2019        PMID: 31806523      PMCID: PMC7539292          DOI: 10.1016/j.schres.2019.10.051

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  55 in total

1.  Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample.

Authors:  Jai L Shah; Anne Crawford; Sally S Mustafa; Srividya N Iyer; Ridha Joober; Ashok K Malla
Journal:  Psychiatr Serv       Date:  2017-06-15       Impact factor: 3.084

2.  Prodromal symptoms and remission following first episode psychosis.

Authors:  Laoise Renwick; John Lyne; Brian O Donoghue; Liz Owens; Roisin Doyle; Michele Hill; Emma McCarthy; Mark Pilling; Eadbhard O'Callaghan; Mary Clarke
Journal:  Schizophr Res       Date:  2015-07-14       Impact factor: 4.939

3.  Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program.

Authors:  John M Kane; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Robert A Rosenheck; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Piper S Meyer-Kalos; Jennifer D Gottlieb; Shirley M Glynn; David W Lynde; Ronny Pipes; Benji T Kurian; Alexander L Miller; Susan T Azrin; Amy B Goldstein; Joanne B Severe; Haiqun Lin; Kyaw J Sint; Majnu John; Robert K Heinssen
Journal:  Am J Psychiatry       Date:  2015-10-20       Impact factor: 18.112

4.  Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study.

Authors:  J Klosterkötter; F Schultze-Lutter; G Gross; G Huber; E M Steinmeyer
Journal:  Acta Psychiatr Scand       Date:  1997-05       Impact factor: 6.392

5.  The early symptoms of schizophrenia.

Authors:  J Chapman
Journal:  Br J Psychiatry       Date:  1966-03       Impact factor: 9.319

6.  Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).

Authors:  Swaran P Singh; John E Cooper; Helen L Fisher; C Jane Tarrant; Tuhina Lloyd; Jumi Banjo; Sarah Corfe; Peter Jones
Journal:  Schizophr Res       Date:  2005-06-22       Impact factor: 4.939

7.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

8.  Symptomatology of the initial prodromal phase in schizophrenia.

Authors:  Philippos Gourzis; Aggeliki Katrivanou; Stavroula Beratis
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

9.  The influence of age and sex on the onset and early course of schizophrenia.

Authors:  H Häfner; K Maurer; W Löffler; A Riecher-Rössler
Journal:  Br J Psychiatry       Date:  1993-01       Impact factor: 9.319

10.  Duration of psychosis and outcome in first-episode schizophrenia.

Authors:  A D Loebel; J A Lieberman; J M Alvir; D I Mayerhoff; S H Geisler; S R Szymanski
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

View more
  5 in total

1.  Early Intervention Services for Schizophrenia: Looking Back and Looking Ahead.

Authors:  Vinod H Srihari; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

2.  Full speed ahead on indicated prevention of psychosis.

Authors:  Scott W Woods; Jimmy Choi; Daniel Mamah
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 49.548

3.  Development of a probability calculator for psychosis risk in children, adolescents, and young adults.

Authors:  Tyler M Moore; Monica E Calkins; Adon F G Rosen; Ellyn R Butler; Kosha Ruparel; Paolo Fusar-Poli; Nikolaos Koutsouleris; Philip McGuire; Tyrone D Cannon; Ruben C Gur; Raquel E Gur
Journal:  Psychol Med       Date:  2021-01-12       Impact factor: 10.592

4.  Community Psychosis Risk Screening: An Instrument Development Investigation.

Authors:  Lauren M Ellman; Jason Schiffman; Vijay A Mittal
Journal:  J Psychiatr Brain Sci       Date:  2020-08-20

5.  Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.

Authors:  Kristin S Cadenhead; Erica Duncan; Jean Addington; Carrie Bearden; Tyrone D Cannon; Barbara A Cornblatt; Dan Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Peter Bauchman; Ayse Belger; Ricardo E Carrión; Franc Donkers; Jason Johannesen; Gregory Light; Margaret Niznikiewicz; Jason Nunag; Brian Roach
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.